Deal Pipeline notes Fried Frank's representation of Merck in its acquisition of Inspire Pharmaceuticals

Deal Pipeline notes Fried Frank's representation of Merck in its acquisition of Inspire Pharmaceuticals

Deal Pipeline noted the Firm's representation of Merck in its definitive agreement to acquire Inspire Pharmaceuticals, Inc. for approximately US$430m. The Fried Frank team was led by corporate partner David N. Shine (NY) and included antitrust partner Peter Guryan (NY), bankruptcy and restructuring partner Gary L. Kaplan (NY), employee benefits & plans, executive compensation partner Laraine S. Rothenberg (NY), litigation partners Douglas W. Baruch (DC) and Gregg L. Weiner (NY), and tax partner Michael J. Alter (DC).

Am Law Daily, Law360 and Mergers & Acquisitions also reported the Firm's role in the Inspire transaction.

news-detail.inc